Skip To Main Content
Catharina Bartmann on Muck Rack

Catharina Bartmann

As seen in: PLOS ONE, BMC Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Catharina

Contact Catharina, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Detection of spike protein in term placentas of COVID-19 vaccinated and/or SARS-CoV-2 infected women

|
By Catharina Bartmann, Vanessa Schmidt, Michael Mörz
| PLOS ONE
Loading metrics Open Access Peer-reviewed Research Article Citation: Bartmann C, Schmidt V, Mörz M, Schwab M, Rehn M, Blau-Schneider B, et al. (2026) Detection of spike protein in term placentas of COVID-19 vaccinated and/or SARS-CoV-2 infected women. PLoS One 21(3): e0344185.
Open in Who Shared Issue with article?

The impact of the early COVID-19 pandemic on maternal mental health during pregnancy and postpartum

|
By Catharina Bartmann, Theresa Kimmel, Petra Davidova, Miriam Kalok
| PLOS ONE
Loading metrics Open Access Peer-reviewed Research Article Citation: Bartmann C, Kimmel T, Davidova P, Kalok M, Essel C, Ben Ahmed F, et al. (2024) The impact of the early COVID-19 pandemic on maternal mental health during pregnancy and postpartum. PLoS ONE 19(9): e0310902.
Open in Who Shared Issue with article?

Ovarian cancer cells regulate their mitochondrial content and high mitochondrial content is associated with a poor prognosis - BMC Cancer

|
By Mariam Petrosyan, Leticia Oliveira-Ferrer, Barbara Schmalfeldt, Jil Weigelt, Catharina Bartmann, Johannes Dietl, Christine Stürken, Udo Schumacher
| BMC Cancer Verified
First, the presence or absence of immunohistochemically detectable mitochondria was validated in human kidneys and in different clinical samples of ovarian cancers using three monoclonal antibodies directed against different mitochondrial antigens, namely HSP60, fumarase and SDHA. All three antibodies detected mitochondria in the proximal tubule of the kidney and the isotype controls were negative (Fig. 1). Individual mitochondria could be identified using the HSP-60 monoclonal antibody (Fig. 2).
Open in Who Shared Issue with article?
See all 3 articles